Table 4 The distinction between receptor status positive/negative patients: comparative performance of image/gene expression-based measurements of immune infiltration for separating receptor status.
From: Integrative multiomics-histopathology analysis for breast cancer classification
KS Test p-value (ER) | KS Test p-value (PR) | Bootstrap Δmean p-value (ER) | Bootstrap Δmean p-value (PR) | |
|---|---|---|---|---|
Visible lymphocyte signal | <2.2E−16 | 4.00E−15 | <1E−05 | <1E−05 |
ESTIMATE Immune infiltration (Yoshihara, et al.) | 5.36E−08 | 2.14E−03 | <1E−05 | 3.40E−03 |
TIMER Immune infiltration (Li, et al.) | 3.75E−07 | 1.40E−02 | <1E−05 | 1.43E−02 |
Pathologic stage (discontinuous distribution) | n/a | n/a | 0.2509 | 0.981 |